Skip to main content
. 2021 May 1;230:234–242. doi: 10.1016/j.ajo.2021.04.014

Table 1.

Summary Statistics Overall and by Visit Type

Total
(N = 1,720)
Deferred
(N = 769)
In Person
(N = 536)
Phone
(N = 320)
Video
(N = 95)
P Value
Age
 Mean (SD) 64.7 (16.8) 64.7 (16.1) 66.8 (17.3) 62.6 (17.8) 59.8 (15.0) <.001
Sex
 Female 1009 (58.7%) 450 (58.5%) 316 (59.0%) 186 (58.1%) 57 (60.0%) .979
 Male 711 (41.3%) 319 (41.5%) 220 (41.0%) 134 (41.9%) 38 (40.0%)
Race
 White 1396 (81.2%) 604 (78.5%) 468 (87.3%) 249 (77.8%) 75 (78.9%) .002
 Black 180 (10.5%) 87 (11.3%) 42 (7.8%) 39 (12.2%) 12 (12.6%)
 Asian 66 (3.8%) 40 (5.2%) 13 (2.4%) 10 (3.1%) 3 (3.2%)
 Other 78 (4.5%) 38 (4.9%) 13 (2.4%) 22 (6.9%) 5 (5.3%)
Ethnicity
 Hispanic 38 (2.3%) 15 (2.1%) 11 (2.1%) 11 (3.7%) 1 (1.1%) .362
 Non-Hispanic 1593 (97.7%) 713 (97.9%) 502 (97.9%) 290 (96.3%) 88 (98.9%)
Median household income
 Mean (SD) 75387 (32696) 76940 (34366) 74657 (31346) 73101 (29641) 74547 (35671) .327
Provider specialty
 Adult strabismus 12 (0.7%) 11 (1.4%) 1 (0.2%) 0 (0.0%) 0 (0.0%) <.001
 Comprehensive & cataract surgery 345 (20.1%) 205 (26.7%) 43 (8.0%) 79 (24.7%) 18 (18.9%)
 Cornea, external disease, & refractive surgery 327 (19.0%) 87 (11.3%) 65 (12.1%) 137 (42.8%) 38 (40.0%)
 Glaucoma 243 (14.1%) 180 (23.4%) 27 (5.0%) 33 (10.3%) 3 (3.2%)
 Neuro-ophthalmology 61 (3.5%) 7 (0.9%) 47 (8.8%) 2 (0.6%) 5 (5.3%)
 Ocular oncology 31 (1.8%) 10 (1.3%) 17 (3.2%) 1 (0.3%) 3 (3.2%)
 Optometry 144 (8.4%) 115 (15.0%) 22 (4.1%) 5 (1.6%) 2 (2.1%)
 Plastics 56 (3.3%) 31 (4.0%) 5 (0.9%) 5 (1.6%) 15 (15.8%)
 Retina, uveitis, & rheumatology 501 (29.1%) 123 (16.0%) 309 (57.6%) 58 (18.1%) 11 (11.6%)
Provider type
 Anterior segment 395 (23.0%) 129 (16.8%) 71 (13.2%) 142 (44.4%) 53 (55.8%) <.001
 Comprehensive 489 (28.4%) 320 (41.6%) 65 (12.1%) 84 (26.2%) 20 (21.1%)
 Posterior segment 836 (48.6%) 320 (41.6%) 400 (74.6%) 94 (29.4%) 22 (23.2%)